Trial Profile
The Impact of Local Estrogen on the Urogenital Microbiome in Genitourinary Syndrome of Menopause (GSM)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Estradiol (Primary)
- Indications Female urogenital diseases
- Focus Therapeutic Use
- 06 Sep 2019 Status changed from recruiting to completed.
- 02 Aug 2019 Planned primary completion date changed from 28 Jun 2019 to 30 Aug 2019.
- 19 Jun 2019 Planned primary completion date changed from 1 May 2019 to 28 Jun 2019.